Earnings Snapshot: Teva Pharmaceutical Industries tops Q4 estimates; initiates FY26 outlook below forecast
Source: SeekingAlpha
2026-01-28 07:38:24 ET
More on Teva Pharmaceutical
- Teva Is No Longer A Turnaround Story; It's A Growth One
- Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Teva Pharmaceutical Non-GAAP EPS of $0.96 beats by $0.32, revenue of $4.71B beats by $380M
- Earnings week ahead: TSLA, META, MSFT, AAPL, T, BA, V, MA, GM, CVX, XOM, and more
Read the full article on Seeking Alpha
For further details see:
Earnings Snapshot: Teva Pharmaceutical Industries tops Q4 estimates; initiates FY26 outlook below forecast
Teva Pharmaceutical Industries Ltd
NASDAQ: TEVJF
TEVJF Trading
43530.77% G/L:
$28.36 Last:
100 Volume:
$28.36 Open:
TEVJF Latest News
June 06, 2025 09:44:00 am
Teva 2024 Healthy Future Report: Health System Strengthening and Capacity Building
TEVJF Stock Data
$39,634,050,594
1,138,314,769
N/A
264
N/A
Pharmaceuticals
Healthcare
IL
Tel Aviv
